The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritis
- PMID: 6606402
- PMCID: PMC1001326
- DOI: 10.1136/ard.42.6.668
The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritis
Abstract
Plasma samples from 44 patients with systemic lupus erythematosus (SLE) and 43 with rheumatoid arthritis (RA) were assayed for C3d, a breakdown product of the third component of complement (C3), which was also measured in parallel. Levels of C3d varied in direct proportion with disease activity in RA, whereas C3 showed little change. Although C3d values also increased with worsening clinical condition in SLE, this trend was not considered to be sufficiently clear to be useful and did not provide any advantage over the routinely performed C3 assay.
Similar articles
-
Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis.J Immunol Methods. 1982;48(1):97-108. doi: 10.1016/0022-1759(82)90214-9. J Immunol Methods. 1982. PMID: 6799579
-
Direct quantitation of activated C3 in human plasma with monoclonal anti-iC3b-C3d-neoantigen.J Immunol Methods. 1986 Apr 3;88(1):33-6. doi: 10.1016/0022-1759(86)90048-7. J Immunol Methods. 1986. PMID: 2420896
-
Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.J Clin Invest. 1985 Oct;76(4):1418-26. doi: 10.1172/JCI112119. J Clin Invest. 1985. PMID: 2932466 Free PMC article.
-
Determination of complement breakdown fragments C3d and its subfragments in health and disease.Diagn Immunol. 1984;2(2):116-21. Diagn Immunol. 1984. PMID: 6333963
-
Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus.Ann Rheum Dis. 1988 Jul;47(7):529-31. doi: 10.1136/ard.47.7.529. Ann Rheum Dis. 1988. PMID: 3041923 Free PMC article. Review. No abstract available.
Cited by
-
Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.Ann Rheum Dis. 1989 Apr;48(4):302-6. doi: 10.1136/ard.48.4.302. Ann Rheum Dis. 1989. PMID: 2785367 Free PMC article.
-
Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.Ann Rheum Dis. 1988 Nov;47(11):913-7. doi: 10.1136/ard.47.11.913. Ann Rheum Dis. 1988. PMID: 3264693 Free PMC article.
-
Differential heat shock protein overexpression and its clinical relevance in systemic lupus erythematosus.Ann Rheum Dis. 1993 Jun;52(6):436-42. doi: 10.1136/ard.52.6.436. Ann Rheum Dis. 1993. PMID: 8323395 Free PMC article.
-
Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients.Clin Exp Immunol. 2014 Jun;176(3):327-35. doi: 10.1111/cei.12274. Clin Exp Immunol. 2014. PMID: 24433281 Free PMC article.
-
SLE and Serum Complement: Causative, Concomitant or Coincidental?Open Rheumatol J. 2017 Sep 30;11:113-122. doi: 10.2174/1874312901711010113. eCollection 2017. Open Rheumatol J. 2017. PMID: 29290848 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous